Back

JCAD: a new GWAS target to reduce residual cardiovascular risk?

European Heart Journal

14 December 2022
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY BASIC SCIENCE

Contributors

Tomasz J Guzik
Tomasz J Guzik

Author

University of Edinburgh Edinburgh , United Kingdom of Great Britain & Northern Ireland

Keith M Channon
Keith M Channon

Author

You may be interested in
thumbnail
Congress Presentation
JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression
28 August 2021
thumbnail
Congress Presentation
Effects of combining coronary calcium score with treatment on plaque progression in familial coronary artery disease: CAUGHT-CAD RCT
1 September 2025
thumbnail
Congress Presentation
Assessment of multi-trait analysis of GWAS (MTAG) for discovery of novel genetic variants and mechanistic insight in common cardiovascular diseases
27 August 2023
thumbnail
Congress Presentation
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources